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INTRODUCTION
Hand-Arm Vibration Syndrome (HAVS) is a major occupational disease that causes considerable morbidity among workers exposed to vibration and is characterized by disorders of the vascular, sensorineural and musculoskeletal systems (Bernard et al., 1998; Friden, 2001; Weir and Lander, 2005) . Approximately 1.45 million workers in the United States are exposed to hand-transmitted vibration, and based on data from epidemiological studies approximately 50% of those workers will develop HAVS (Bernard et al., 1998) . The predominant vascular disorder is heightened constriction of digital arteries resulting in reduced cutaneous blood flow (Friden, 2001; Weir and Lander, 2005) . The onset and progression of the disease is poorly understood at the cellular and molecular level. Although heightened activity of the sympathetic nervous system and endothelial injury have been proposed as important pathogenic mechanisms, clinical studies have demonstrated reduced vasoconstriction to α-adrenergic activation and normal dilation to the endothelium-dependent agonist acetylcholine in individuals who use vibrating tools (Ekenvall and Lindblad, 1986; Chen et al., 1994; Kennedy et al., 1999; Stoyneva et al., 2003) . HAVS may also be associated with medial thickening and smooth muscle hypertrophy, resulting in increased wall:lumen ratios and reduced internal diameters in small arteries and arterioles (Takeuchi et al., 1986; Kent et al., 1991; Greenstein et al., 1994; Hashiguchi et al., JPET #144618 palm, and wrist ( Figure 1 ). Software (Version 2B, Polytec, Germany) collected and recorded velocity measurements from several locations along the dorsal surface paw.
Vibration transmissibility: Three rats were used to measure the vibration transmissibility in the rat paw to characterize the response of the paw to segmental vibration exposure. Prior to testing, these rats were lightly anesthetized with xylazine (5 mg/kg) and ketamine (40 mg/kg) to keep their paws completely still during operation of the scanning laser vibrometer. The anesthetized rat was placed in cone-shape plastic bag and placed over the shaker as described above. Velocity measurements were recorded from several locations along the dorsal surface of the paw, plus a reference point on the surface of the vibrating platform next to the paw. Six different vibration frequencies (32.5 Hz, 63 Hz, 125 Hz, 160 Hz, 250 Hz, and 500 Hz) were tested at three different unweighted accelerations (9.8 m/s 2 , 49 m/s 2 , and 100 m/s 2 ). Measurement at each location lasted approximately 5 s -long enough for the software to record a reliable measurement.
Vibration exposure: A separate set of non-anesthetized rats were used for in vitro analyses of vascular function. Each rat was randomly assigned to one of two groups: a vibration-exposed group or a restraint-control group. Rats in the vibration group were exposed to a 4-hr period of vibration at 125 Hz and a constant acceleration of 49 m/s 2 root meaned squared. The biodynamic response of the paw to this frequency and acceleration was fairly consistent at all measurement locations ( Figure 2 ). In addition, exposure to tools with a dominant vibration frequency near 125
Hz is associated with the development of HAVS in humans (Bovenzi et al., 1988) . Rats in the restraint-control group were similarly restrained and placed in the same exposure chamber except no vibration was applied to their paws or forelimbs. Exposure chambers were equipped with a video camera to monitor rats throughout the exposure and ensure that each rat's paw stayed in contact with the vibrating platform at all times. After exposures, the rats were euthanatized This article has not been copyedited and formatted. The final version may differ from this version. (control solution). Arteries were cannulated at both ends with glass micropipettes, secured using 12-0 nylon monofilament suture, and placed in a microvascular chamber (Living Systems, Burlington, VT). The chamber was superfused with control solution, maintained at 37°C, pH 7.4
(gassed with 16% O 2 -5% CO 2 -balance N 2 ), and the artery segment pressurized to a constant transmural pressure (P TM ) of 60 mm Hg (Krajnak et al., 2006) . The chamber was placed on the stage of an inverted microscope (X10, Nikon Eclipse TS100, Japan) and connected to a video camera (Sony, CCTV camera, Japan). The vessel image was projected onto a video monitor, and the internal diameter continuously determined by a video dimension analyzer (Living Systems JPET #144618 generated by increasing the concentration of the agonists in half-log increments, once the constriction to the previous concentration had stabilized. After each concentration-effect curve was completed, the agonist was removed from the superfusate and the artery was allowed to return to its baseline level for 30 minutes before beginning the next curve. Cumulative concentration-response curves to acetylcholine (0.001-1 µM), substance P (0.001-1 µM) or sodium nitroprusside (SNP) (0.001-1 µM) were obtained following constriction of the arteries to ~50% of the stable baseline diameter with phenylephrine.
Concentration-effect curves to constrictor agonists were determined in the absence and presence of the nitric oxide synthase (NOS) inhibitor, N G -nitro-L-arginine methyl ester (L-NAME; 100 µM), or catalase (1,000 units/ml), which degrades extracellular hydrogen peroxide (H 2 O 2 ). When inhibitors were used, the preparations were incubated with the drugs for 30 min before and then during exposure of the arteries to the agonist. Only one inhibitor was assessed in each blood vessel. Time control experiments, in which the arteries were incubated for a similar time without inhibitors, demonstrated that sequential concentration-effect curves to phenylephrine and to 5-HT were similar (data not shown).
After all vasoconstriction curves were recorded, the perfusion solution was switched to calcium-free control solution (containing 3 mM EGTA) and passive diameter at 60 mmHg was recorded.
Nitric Oxide (NO): NO activity of digital arteries from control and vibrated paws was determined using the NO-sensitive fluorescent probe 4-amino-5-methylamino-2', 7'-difluorofluorescein diacetate (DAF-FM DA) (Molecular Probes, Eugene, Oregon) (Santhanam et al., 2007; Ryoo et al., 2008) . Digital arteries were pinned in a Silastic-coated dish in Hepes arteries were treated with L-NAME (100 µM) or catalase (1,000 U/ml) before, during and after the incubation with DCDHF. In control and vibrated arteries, DCDHF fluorescence was virtually abolished by treatment with the antioxidant N-acetylcysteine (20 mM)(data not shown).
The average fluorescent intensity was calculated for each group. 
RESULTS
BIODYNAMIC ANALYSES
Vibration transmissibility from 32 Hz to 250 Hz was at or slightly above 1.0 in the digits and palm at 9.8 m/s 2 rms and 49 m/s 2 rms (Figure 2 ). At 100 m/s 2 rms and at the higher frequencies, transmissibility in the palm and wrist was less than 1.0
FUNCTIONAL ANALYSES
For the functional studies, rats in the vibrated group were exposed to a 4-hr period of vibration at 125 Hz and constant acceleration of 49 m/s 2 root mean squared. At a transmural pressure of 60 mmHg, the baseline diameters of control and vibrated digital arteries were similar (211 + 6 and 196 + 6 µm, respectively, n = 18; P = not significant or NS). In the absence of constrictor agonists, these arteries did not display significant basal tone.
Vibration Does Not Affect Vasodilator Agonist Responses
Vasodilator responses to the endothelial agonists, acetylcholine or substance P (0.001-1 µM) were analyzed during constriction of arteries to phenylephrine (by ~ 50% of baseline diameter). There was no difference in vasodilation concentration-effect curves between control and vibrated arteries in response to either agonist (P = NS), whether assessed in the absence or presence of the NO synthase (NOS) inhibitor L-NAME (100 μM) (Figure 3 ). L-NAME (100 Role of the Endothelium: Endothelial-denudation decreased constriction to phenylephrine or 5-HT in control (P < 0.05) but not vibrated arteries, and eliminated the vibration-induced decrease in agonist responses (figure 5).
Role of NO:
The NOS inhibitor L-NAME (100 µM) increased vasoconstriction to phenylephrine or 5-HT in vibrated (P < 0.05) but not control arteries, and abolished the vibration-induced depression in vasoconstrictor responses ( Figure 6 ).
NO activity, determined using the NO-sensitive fluorescent probe DAF-FM DA, was significantly reduced in arteries from vibrated compared to control paws (P < 0.05) ( Figure 7A ).
Role of ROS:
Endogenous levels of ROS, which were determined using the ROS-sensitive fluorescent probe DCDHF, were significantly increased in vibrated compared to control digital arteries (P < 0.01) ( Figure 7B ). Degradation of extracellular H 2 O 2 by catalase (1,000 units/ml) did not influence ROS levels in control arteries but significantly reduced the increased oxidant levels in arteries from vibrated paws (P < 0.01)( Figure 7B ). Inhibition of NOS by L-NAME also significantly reduced oxidant activity in arteries from vibrated (P < 0.01) but not control paws Vibration-induced soft tissue damage is believed to be dependent on the amount of tissue stress and strain, which can be estimated by calculating the transmissibility of the vibration stimulus to the tissue (Dong et al., 2005; Wu et al., 2006) . The transmission of vibration to the paw was frequency and location dependent as it is in the hand-arm system. In humans, exposures to lower vibration frequencies (32 Hz to 63 Hz) affect the whole hand-arm system, whereas exposures to higher vibration frequencies (100 Hz to 350 Hz) preferentially affect the fingers and hands (Sorensson and Lundstrom, 1992; Dong et al., 2004) . The responses of the fingers to vibration are also frequency dependent, with transmissibility at the higher frequencies usually being greater than one (Sorensson and Lundstrom, 1992; Dong et al., 2004) . In the rat This article has not been copyedited and formatted. The final version may differ from this version. paw and digits transmissibility was also at or slightly above 1.0 between 63 and 250 Hz.
Transmissibility in the rat paw was less than that observed in human fingers (Dong et al., 2005) or rat tails (Welcome, et al., in press ), which may be explained by their differences in mass and stiffness. However, the results demonstrate that the paw model can be used to study the effects of vibration and provide mechanistic insight into how vibration causes pathological changes in the hand-arm system.
Exposure of rat paws to a single period of vibration caused a long-lasting depression in vasoconstrictor responses of digital arteries to activation of α 1 -ARs or serotonergic receptors.
This generalized decrease in contractile activity would be consistent with a proposed vibrationinduced disruption of smooth muscle cell integrity (Curry et al., 2002) . However, the vibrationinduced depression in constriction was prevented by endothelial-denudation indicating that it resulted from altered activity of endothelial rather than smooth muscle cells. Although endothelial cells can express serotonergic receptors, functional α 1 -ARs are not present on arterial endothelium. Therefore, the vibration-induced, endothelium-dependent depression in constrictor responses would be consistent with basal rather than stimulated activity (by phenylephrine or 5-HT) of an endothelial mediator. Indeed, vibration did not alter the magnitude of endotheliumdependent relaxations evoked by the endothelial activators, acetylcholine or Substance P. The vibration-induced depression in vasoconstriction was also prevented by inhibition of NOS with L-NAME, which would be consistent with a vibration-induced increase in basal NO activity.
Surprisingly, the basal activity of NO, assessed using the fluorescent probe DAF-FM, was actually reduced in vibrated arteries. In contrast, the basal levels of ROS, assessed using the ROS-sensitive probe DCDHF, was dramatically increased in vibrated arteries. The vibrationinduced increase in levels of ROS was abolished by L-NAME suggesting that in vibrated This article has not been copyedited and formatted. The final version may differ from this version. constrictor responses in endothelium-containing arteries, but had no effect in endotheliumdenuded arteries (data not shown), thereby revealing an endothelium-dependent constrictor influence (cf. Figures 5 and 6 ). Therefore, although there appears to be no net basal effect of the endothelium in vibrated arteries, this actually reflects a balanced activity of endothelium-derived contracting and dilating mediators. The major difference between control and vibrated arteries and the reason for the interesting divergent shifts in the concentration-effect curves appears to be the dramatic increase in endothelial (and NOS-dependent) dilator activity in vibrated arteries and maintained activity of endothelium-derived contractile factors in control and vibrated arteries.
The endothelium-derived dilator in vibrated arteries appears to be H 2 O 2 , whereas the nature of the contracting factor was not pursued.
Vibration increased endothelial dilator activity under basal conditions, but did not change the magnitude of endothelium-dependent relaxation to endothelial agonists, acetylcholine and Substance P. Although NOS uncoupling can reduce endothelium-dependent responses to these agonists, the NOS-dependent generation of H 2 O 2 can also effectively substitute for NOS-derived NO enabling maintained relaxation (Cosentino and Katusic, 1995) . The selective vibrationinduced increase in endothelial dilator activity under basal conditions could result from persistent basal activation of the endothelium in vibrated arteries or from different subcellular compartments of NOS.
A vibration-induced diminution in constrictor activity maybe a somewhat surprising finding because HAVS is characterized by exaggerated vasoconstriction (Weir and Lander, 2005) . However, clinical and in vitro studies have also demonstrated diminished responses to vasoconstrictor stimuli in individuals or in isolated blood vessels exposed to vibration (Ekenvall and Lindblad, 1986; Lindblad et al., 1986; Chen et al., 1994 act as a temporary compensatory mechanism to maintain vasodilatation and decrease vasoconstriction, sustained exposure to high levels of oxidants could contribute to disease progression. NO is vasoprotective and acts to inhibit platelet aggregation and adhesion, and to vascular remodeling and inflammation, whereas H 2 O 2 and other oxidants can initiate pathological changes in the vasculature, stimulating inflammatory genes, vascular remodeling and enhanced vasoconstriction (Boulden et al., 2006; Forstermann, 2006; Forstermann and Munzel, 2006) . Indeed, NOS uncoupling and subsequent oxidative stress are thought to contribute to many cardiovascular disorders including hypertension, atherosclerosis and diabetes (Cosentino et al., 1998; Oelze et al., 2000; Hink et al., 2001; Landmesser et al., 2003; Forstermann, 2006; Forstermann and Munzel, 2006) and may be an important early step in the vasculopathy of HAVS. Chronic exposure to vibration injury, by causing persistent oxidant stress and loss of NO activity, could then contribute to structural and functional pathological changes in these blood vessels and disease progression. Therapy targeted towards preserving NO activity may be beneficial in this disease process.
This article has not been copyedited and formatted. The final version may differ from this version. Vasoconstrictor responses were significantly different between control and vibrated arteries for each agonist. *** P < 0.001. both vasoconstrictor agonists when compared to controls (P < 0.001). L-NAME increased vasoconstriction to phenylephrine or to 5-HT in vibrated (P < 0.05) but not control arteries. After L-NAME, vasoconstrictor responses were similar in digital arteries from control and vibrated paws. *** P<0.001, * P < 0.05, NS not statistically significant, with brackets and symbols indicating comparisons. 
